The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Interested in all sessions Cellular Therapy/Biotherapies? Then this is the package for you. We have also thrown in a couple of additional sessions you might also find interesting…
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…
CABP CE Eligible
This session equips blood bank, transfusion medicine, and biotherapies professionals with practical tools for robust risk assessment. Risk identification methods and customizing risk registers for specific practice areas will be covered. Key steps in the risk assessment process like evaluation, prioritization and monitoring will be explored. Techniques for proactively assessing vulnerabilities across the full spectrum of operations, from donor screening and component preparation to blood administration will be discussed. Best practices for risk assessment, including evaluating risk levels and predictability, will be presented. Real case examples demonstrate how targeted risk mitigation enhances patient outcomes and ensures the safety of blood and biotherapies. Attendees will gain skills applicable to establishing customized risk management programs tailored to their unique needs.
Learning Objectives
Describe the key steps in the risk assessment process for Blood Bank, Transfusion Services, and Biotherapies
Apply techniques for identifying risks tailored to their specific practice areas and workflows
Analyze potential vulnerabilities and prioritize risks according to impact and likelihood within their facilities
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM24-TU-11-O: Managing Risk, Maximizing Safety: The Essentials of Proactive Risk Assessment (Enduring) Evaluation
Decentralized manufacturing has become a prominent focus in the Advanced Therapies space as the number of therapies in development increases and patient volumes surge with earlier line treatment objectives…
The Biotherapies Spotlight Session will cover several diverse topics. The use of controlled incremental filtration microfluidics rather than monoclonal antibody selection systems to isolate B-cells from whole blood will be discussed…
This session will highlight advances in three areas of platelet research; stabilization methods through lyophilization, iPSC ex-vivo production, and synthetic nanoparticle technology are converging and can lead to long-lived platelet-based therapies targeted to address specific related pathologies…
A presentation of how one facility tackled a massive inventory reduction project to discard cell therapy products that had been in LN2 storage for 10 to 25 years…